ID

42160

Description

Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01392898

Link

https://clinicaltrials.gov/show/NCT01392898

Keywords

Versions (2)
  1. 3/13/16 3/13/16 -
  2. 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
Uploaded on

April 13, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes Mellitus NCT01392898

English

Eligibility Type 2 Diabetes Mellitus NCT01392898

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with type 2 diabetes mellitus on short-term insulin therapy (≤ 12 months); all types of insulin allowed
Description

diabetes mellitus type 2; insulin therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
UMLS CUI [2]
C0557978
documented insulin-associated weight gain ≥ 3.0 kg from the start of insulin therapy until inclusion
Description

weight gain; insulin therapy

Data type

boolean

Alias
UMLS CUI [1]
C0043094
UMLS CUI [2]
C0557978
age 18-75 years
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
bmi ≥ 25 kg/m2
Description

bmi

Data type

boolean

Alias
UMLS CUI [1]
C1305855
stable glycaemic control mirrored by hba1c ≥ 6.5 and ≤ 8.5 %
Description

hba1c

Data type

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to provide informed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
type 1 diabetes mellitus, mody diabetes, or lada diabetes (presence of anti-gad)
Description

Diabetes type 1; mody diabetes; lada diabetes

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441729
UMLS CUI [2]
C0342276
UMLS CUI [3]
C1960272
presence of any medical condition that might interfere with the current study protocol.
Description

Compliance behavior Limited Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
inflammatory bowel disease (e.g. m. crohn, ulcerative colitis)
Description

inflammatory bowel disease; Crohn Disease

Data type

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0010346
recurrent hypoglycaemic events
Description

hypoglycaemic event recurrent

Data type

boolean

Alias
UMLS CUI [1,1]
C0342312
UMLS CUI [1,2]
C2945760
diabetic gastroparesis
Description

diabetic gastroparesis

Data type

boolean

Alias
UMLS CUI [1]
C0267176
heart failure (lvef ≤ 30%)
Description

lvef ; heart failure

Data type

boolean

Alias
UMLS CUI [1]
C0428772
UMLS CUI [2]
C0018801
use of tzds (glitazones), ddp-iv (dipeptidylpeptidase-inhibitor)
Description

Thiazolidinediones

Data type

boolean

Alias
UMLS CUI [1]
C1257987
use of medication associated with impaired glucose metabolism including corticosteroids
Description

Adverse reaction to drug; glucose metabolism; corticosteroids

Data type

boolean

Alias
UMLS CUI [1]
C0041755
UMLS CUI [2]
C0596620
UMLS CUI [3]
C0001617
pregnancy or breast-feeding (contraception of at least 3 months before inclusion is required for fertile women)
Description

pregnancy; lactating

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
pre-existing thyroid disease
Description

thyroid disease

Data type

boolean

Alias
UMLS CUI [1]
C0040128
liver disease (aspartate aminotransferase or alanine aminotransferase level of more than three times the upper limit of normal range)
Description

liver disease; aspartate aminotransferase level; alanine aminotransferase level

Data type

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2,1]
C0428339
UMLS CUI [2,2]
C1272112
renal disease (creatinine > 130 µmol/l or mdrd-gfr <30 ml/min/1.73m2)
Description

renal disease; creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C0201975
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01392898

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2; insulin therapy
Item
patients with type 2 diabetes mellitus on short-term insulin therapy (≤ 12 months); all types of insulin allowed
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
C0557978 (UMLS CUI [2])
weight gain; insulin therapy
Item
documented insulin-associated weight gain ≥ 3.0 kg from the start of insulin therapy until inclusion
boolean
C0043094 (UMLS CUI [1])
C0557978 (UMLS CUI [2])
age
Item
age 18-75 years
boolean
C0001779 (UMLS CUI [1])
bmi
Item
bmi ≥ 25 kg/m2
boolean
C1305855 (UMLS CUI [1])
hba1c
Item
stable glycaemic control mirrored by hba1c ≥ 6.5 and ≤ 8.5 %
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
informed consent
Item
inability to provide informed consent
boolean
C0021430 (UMLS CUI [1])
Diabetes type 1; mody diabetes; lada diabetes
Item
type 1 diabetes mellitus, mody diabetes, or lada diabetes (presence of anti-gad)
boolean
C0011849 (UMLS CUI [1,1])
C0441729 (UMLS CUI [1,2])
C0342276 (UMLS CUI [2])
C1960272 (UMLS CUI [3])
Compliance behavior Limited Comorbidity
Item
presence of any medical condition that might interfere with the current study protocol.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
inflammatory bowel disease; Crohn Disease
Item
inflammatory bowel disease (e.g. m. crohn, ulcerative colitis)
boolean
C0021390 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
hypoglycaemic event recurrent
Item
recurrent hypoglycaemic events
boolean
C0342312 (UMLS CUI [1,1])
C2945760 (UMLS CUI [1,2])
diabetic gastroparesis
Item
diabetic gastroparesis
boolean
C0267176 (UMLS CUI [1])
lvef ; heart failure
Item
heart failure (lvef ≤ 30%)
boolean
C0428772 (UMLS CUI [1])
C0018801 (UMLS CUI [2])
Thiazolidinediones
Item
use of tzds (glitazones), ddp-iv (dipeptidylpeptidase-inhibitor)
boolean
C1257987 (UMLS CUI [1])
Adverse reaction to drug; glucose metabolism; corticosteroids
Item
use of medication associated with impaired glucose metabolism including corticosteroids
boolean
C0041755 (UMLS CUI [1])
C0596620 (UMLS CUI [2])
C0001617 (UMLS CUI [3])
pregnancy; lactating
Item
pregnancy or breast-feeding (contraception of at least 3 months before inclusion is required for fertile women)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
thyroid disease
Item
pre-existing thyroid disease
boolean
C0040128 (UMLS CUI [1])
liver disease; aspartate aminotransferase level; alanine aminotransferase level
Item
liver disease (aspartate aminotransferase or alanine aminotransferase level of more than three times the upper limit of normal range)
boolean
C0023895 (UMLS CUI [1])
C0428339 (UMLS CUI [2,1])
C1272112 (UMLS CUI [2,2])
renal disease; creatinine
Item
renal disease (creatinine > 130 µmol/l or mdrd-gfr <30 ml/min/1.73m2)
boolean
C0022658 (UMLS CUI [1])
C0201975 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial